ORYZON reports financial results and corporate update for quarter ended September 30, 2024 28/10/2024 Healthcare Advanced therapies Financing Final data from PORTICO, global Phase IIb vafidemstat trial in BPD,presented at the 37th ECNP annual conference in... Partners - Oryzon Genomics
AEMPS approves Peaches' clinical trial with selective secretomes to treat COVID-19-associa... 10/10/2024 Healthcare Innovative drugs Personalized medicine Advanced therapies Peaches starts its phase I-II pilot trial to obtain an advanced biologic drug that will help combat cytokine storm, a... Partners - PEACHES BIOTECH S.L.
Alira Health Releases 2024 Biologics and Advanced Therapies CDMO Market Report Amid Contin... 02/10/2024 Healthcare Drug discovery Advanced therapies International Despite market contraction in 2023, strategic interest in biologics and advanced therapies remains robust, with a... Partners
Peaches Biotech participates in the 4D-BIOSKIN consortium for the production of human skin... 25/09/2024 Healthcare Access to innovation Advanced therapies This regenerative medicine project will carry out the first clinical trial in Spain to treat burns and skin wounds with... Partners - PEACHES BIOTECH S.L.
Klinea BioPharmaceutical Engineering is #Biotech 25/09/2024 Healthcare Advanced therapies Klinea, part of an innovation ecosystem in Advanced Therapies. Partners - Klinea Biotech & Pharma Engineering
Vafidemstat emerges as a promising treatment for Borderline Personality Disorder 24/09/2024 Healthcare Advanced therapies Oryzon Genomics, a clinical-stage biopharmaceutical company, is advancing vafidemstat, its LSD1 inhibitor for CNS... Partners - Oryzon Genomics
Biotechnology plays a crucial role in the latest advances against Alzheimer's 21/09/2024 Healthcare Innovative drugs Personalized medicine Advanced therapies Biotechnology is behind every medication being tested and eventually approved, making its contribution the key factor... AseBio
Biotechnology plays a crucial role in the latest advances against Alzheimer's 21/09/2024 Nearly two decades ago, the first group of compounds to treat Alzheimer's disease were approved, but they do not stop... AseBio
Revolutionary CAR-T Cell Therapies: A New Era in Cancer Treatment 17/09/2024 Healthcare Advanced therapies Promega's contribution to the development and verification of genetically modified CAR-T cells is driving innovation in... Partners - Promega
Biotechnology revolutionizes the diagnosis and treatment of lymphoma, the seventh most com... 15/09/2024 Healthcare Rare diseases Personalized medicine Advanced therapies It is estimated that in 2024, around 12,400 new cases of lymphoma will be diagnosed in Spain, the majority... AseBio
